Book Building - SME
₹ - cr
₹ 0
-
₹ -
NSE - SME
-
-
-
Initial public offering of up to 43,40,000* equity shares of face value of Rs. 10 each (The Equity Shares), at an offer price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores[Public Offer] comprising of a fresh issue of up to 36,40,000 equity shares aggregating Rs. [*] crores [Fresh Issue] and an offer for sale of up to 7,00,000 equity shares aggregating to Rs. [*] comprising an offer of up to 1,00,000 equity shares aggregating to Rs. [*] crores by Mr. Vikash Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Mr. Vivek Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Mr. Vishal Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Ushadevi Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Pooja Rajgarhia, up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Priti Rajgarhia and up to 1,00,000 equity shares aggregating to Rs. [*] crores by Ms. Archana Rajgarhia (The promoters/promoter group selling shareholders) out of which up to [*] equity shares of face value of Rs. 10 each, at an offer price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores will be reserved for subscription by the market maker to the offer (The Market Maker Reservation Portion). The offer less market maker reservation portion i.e. Offer of [*] equity shares of face value of Rs. 10 each, at an offer price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the Net Offer. The public offer and net offer will constitute [*]% and [*]% respectively of the post- offer paid-up equity share capital of the company.The Face value of the equity shares is Rs. 10 each.
Purchasing capital equipment for new manufacturing facility. Funding working capital requirements of the company. General corporate purposes.
Finecure Pharmaceuticals Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - compliance@finecurepharma.com
Website - www.finecurepharma.com